Cargando…
1732. A Canine Target Species Challenge Model to Evaluate Efficacy of a Coccidioidomycosis Vaccine
BACKGROUND: The preferred efficacy design for licensing a vaccine for animal use (United States Department of Agriculture (USDA)) is a prospective, placebo-controlled, randomized, and double-blinded vaccination-challenge trial. In such studies, each subject receives the same exposure to the virulent...
Autores principales: | Shubitz, Lisa F, Bowen, Richaard, Robb, Edward J, Powell, Daniel A, Bosco-Lauth, Angela, Hartwig, Airn, Trinh, Hien, Lewis, Maria L, Frelinger, Jeffrey A, Galgiani, John N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809339/ http://dx.doi.org/10.1093/ofid/ofz360.1595 |
Ejemplares similares
-
Δcps1 vaccine protects dogs against experimentally induced coccidioidomycosis
por: Shubitz, Lisa F., et al.
Publicado: (2021) -
Vaccine Protection of Mice With Primary Immunodeficiencies Against Disseminated Coccidioidomycosis
por: Powell, Daniel A., et al.
Publicado: (2022) -
Reactivation of Coccidioidomycosis in a Mouse Model of Asymptomatic Controlled Disease
por: Shubitz, Lisa F., et al.
Publicado: (2022) -
2888. STAT4 Mutation in Three Generations with Disseminated Coccidioidomycosis (DCM) also Exhibits Increased Susceptibility to Coccidioidal Infection in Transfected Mice
por: Powell, Daniel A, et al.
Publicado: (2019) -
Development of a Hamster Model for Chikungunya Virus Infection and Pathogenesis
por: Bosco-Lauth, Angela M., et al.
Publicado: (2015)